Terms: = Endocrine gland cancer AND RMI2, MGC24665, 116028, C16orf75, ENSG00000175643 AND Diagnosis
3 results:
1. Comparisons of Effectiveness in Differentiating Benign from Malignant Ovarian Masses between Conventional and Modified Risk of Malignancy Index (RMI).
Tantipalakorn C; Tinnangwattana D; Lerthiranwong T; Luewan S; Tongsong T
Int J Environ Res Public Health; 2023 Jan; 20(1):. PubMed ID: 36613208
[TBL] [Abstract] [Full Text] [Related]
2. The accuracy of risk malignancy index in prediction of malignancy in women with adnexal mass in Basrah, Iraq.
Al-Asadi JN; Al-Maliki SK; Al-Dahhhan F; Al-Naama L; Suood F
Niger J Clin Pract; 2018 Oct; 21(10):1254-1259. PubMed ID: 30297555
[TBL] [Abstract] [Full Text] [Related]
3. Should cut-off values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations?
Yavuzcan A; Caglar M; Ozgu E; Ustun Y; Dilbaz S; Ozdemir I; Yildiz E; Gungor T; Kumru S
Asian Pac J Cancer Prev; 2013; 14(9):5455-9. PubMed ID: 24175841
[TBL] [Abstract] [Full Text] [Related]